A Study of LY4257496 in Participants With Cancer (OMNIRAY)
J6C-OX-JKFA
Phase 1 other active
Quick answer
A Study of LY4257496 in Participants With Cancer (OMNIRAY) for Breast Neoplasms Colorectal Neoplasms Prostate Neoplasm Endometrial Neoplasms Neoplasm Metastasis is a Phase 1 program (other) at Eli Lilly Co. with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Eli Lilly Co.
- Indication
- Breast Neoplasms Colorectal Neoplasms Prostate Neoplasm Endometrial Neoplasms Neoplasm Metastasis
- Phase
- Phase 1
- Modality
- other
- Status
- active